Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Werewolf Therapeutics (HOWL) Interest & Investment Income (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Interest & Investment Income for 5 consecutive years, with $564000.0 as the latest value for Q4 2025.

  • Quarterly Interest & Investment Income fell 56.91% to $564000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.1 million through Dec 2025, down 53.42% year-over-year, with the annual reading at $3.1 million for FY2025, 53.42% down from the prior year.
  • Interest & Investment Income for Q4 2025 was $564000.0 at Werewolf Therapeutics, down from $697000.0 in the prior quarter.
  • The five-year high for Interest & Investment Income was $2.0 million in Q4 2023, with the low at -$34000.0 in Q4 2021.
  • Average Interest & Investment Income over 5 years is $959650.0, with a median of $923500.0 recorded in 2025.
  • The sharpest move saw Interest & Investment Income soared 3794.87% in 2023, then crashed 56.91% in 2025.
  • Over 5 years, Interest & Investment Income stood at -$34000.0 in 2021, then skyrocketed by 3567.65% to $1.2 million in 2022, then surged by 67.51% to $2.0 million in 2023, then tumbled by 33.72% to $1.3 million in 2024, then plummeted by 56.91% to $564000.0 in 2025.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at $564000.0, $697000.0, and $850000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.